UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 24, 2022
Accession Number:
0001213900-22-031186
Submission Type:
POS AM
CIK:
0001690080
Company Name:
180 Life Sciences Corp.
File Number:
333-259209